Viewing Study NCT02606461

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:24 PM
Ignite Modification Date: 2026-01-28 @ 12:15 AM
Study NCT ID: NCT02606461
Status: COMPLETED
Last Update Posted: 2023-01-23
First Post: 2015-10-13
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Selinexor in Advanced Liposarcoma
Sponsor: Karyopharm Therapeutics Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Dedifferentiated Liposarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Advanced unresectable dedifferentiated liposarcoma View
None selinexor View
None KCP-330 View
None Karyopharm View
None Phase 2 / 3 View
None dedifferentiated liposarcoma View
None Liposarcoma View